Content
All Posts > Content under Pharma/Biotech
Smoke Gets In Your Eyes
Article By:
Tim Knight
Read
Thursday, October 10, 2019 5:00 PM EDT
Pot stocks just keep getting destroyed.
These 7 Indexes Track The Performance Of Pot Stocks - Which Are The Best & Why?
Article By:
Lorimer Wilson
Read
Thursday, October 10, 2019 4:47 AM EDT
The marijuana market consists of 313 companies from which various numbers of them are included in 7 indexes. Which ones are the best?
Your Ultimate Guide To Pot Stock Investing
Article By:
Lorimer Wilson
Read
Sunday, October 6, 2019 10:28 PM EDT
I have identified 7 sub-sectors within the overall cannabis market that are worth your attention as the performance of each has varied considerably ranging from +12% to -30.6% in September. Which sub-sector is right for you?
Week In Review: Suzhou Innovent Raises $300 Million To Develop New Products
Article By:
ChinaBio® Today
Read
Saturday, October 5, 2019 3:27 PM EDT
Suzhou Innovent Biologics raised $300 million in a secondary offering to develop three in-licensed products from Incyte and two first-in-class bispecifics.
In this article: ASLN
It's Been A Terrific Bull Market. Too Bad It Has To End
Article By:
David Moadel
Read
Friday, October 4, 2019 2:30 AM EDT
Bull markets don't die of old age, but few will mourn the end of the decade-long ultimate sucker's rally.
Cannabis Central: Wall Street Analysts Recommend These 14 "Pot" Stocks
Article By:
Lorimer Wilson
Read
Friday, October 4, 2019 1:12 AM EDT
Here are 14 pot stocks followed by Wall Street analysts. I detail their buy/hold/sell recommendations for the 7 companies with market capitalizations of C$1B or more, share prices of C$5/share or more & covered by at least 10 analysts.
In this article: CGC, CRON, TLRY, ACB, APHA, CURLF, HEXO, ITHUF, MMNFF, GTBIF, CWBHF, HRVSF, TCNNF, VFF
Cannabis Central: These 12 Marijuana-Related Stocks Pay Dividends And Low Volatility
Article By:
Lorimer Wilson
Read
Thursday, October 3, 2019 4:42 AM EDT
12 consumer goods & bio-pharmaceutical companies have indirect exposure to the marijuana sector, pay dividends and have below-average beta scores. Perhaps one or more of them warrants your investment consideration.
Cannabis Central: Current Stock Prices Don't Reflect Success Of Foray Into Europe
Article By:
Lorimer Wilson
Read
Wednesday, October 2, 2019 4:36 AM EDT
The European CBD industry is forecast to grow by 400% in the next 5 years making it the largest legal cannabis market in the world and a great opportunity for companies to enter or expand their business there.
Cannabis Central: Extraction Stocks Continue On Sale - Down 9.3% In September
Article By:
Lorimer Wilson
Read
Tuesday, October 1, 2019 5:20 AM EDT
With more countries legalizing medical cannabis, the extraction of the plant's oils to meet the demand for vapes, oils, tinctures, edibles, beverages, capsules, and shatter* are likely to outpace the sales of dried flower once these markets mature.
Cannabis Central: Marijuana-Infused Beverage Stocks Remain On Sale
Article By:
Lorimer Wilson
Read
Monday, September 30, 2019 8:00 AM EDT
Could these 6 fledgling marijuana-infused beverage stocks be ideally positioned - and priced - to take full advantage of the coming introduction of edibles in Canada this December? Time will tell.
Daily Stock Tip: Sanofi (SNY)
Article By:
Fredrik Arnold
Read
Monday, September 30, 2019 5:36 AM EDT
Sanofi's price per share closed at $46.26 Friday. A year ago its price was $44.67. In the past year, its price increased by $1.59 or 3.5%.
In this article: SNY
